BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Phaëton R, Gutierrez J, Jiang Z, Karabakhtsian RG, Albanese J, Sunkara J, Fisher DR, Goldberg GL, Dadachova E. Naive and radiolabeled antibodies to E6 and E7 HPV-16 oncoproteins show pronounced antitumor activity in experimental cervical cancer. Immunotherapy 2015;7:631-40. [PMID: 26098137 DOI: 10.2217/imt.15.18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
Number Citing Articles
1 Lifsics A, Groma V, Cistjakovs M, Skuja S, Deksnis R, Murovska M. Identification of High-Risk Human Papillomavirus DNA, p16, and E6/E7 Oncoproteins in Laryngeal and Hypopharyngeal Squamous Cell Carcinomas. Viruses 2021;13:1008. [PMID: 34072187 DOI: 10.3390/v13061008] [Reference Citation Analysis]
2 Dalla Libera LS, de Siqueira T, Santos IL, Porto Ramos JE, Milhomen AX, Alencar RCG, Rabelo Santos SH, Dos Santos Carneiro MA, Figueiredo Alves RR, Saddi VA. Detection of Human papillomavirus and the role of p16INK4a in colorectal carcinomas. PLoS One 2020;15:e0235065. [PMID: 32584870 DOI: 10.1371/journal.pone.0235065] [Reference Citation Analysis]
3 Lin Y, Chen Z, Hu C, Chen Z, Zhang L. Recent progress in antitumor functions of the intracellular antibodies. Drug Discovery Today 2020;25:1109-20. [DOI: 10.1016/j.drudis.2020.02.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Dong Z, Hu R, Du Y, Tan L, Li L, Du J, Bai L, Ma Y, Cui H. Immunodiagnosis and Immunotherapeutics Based on Human Papillomavirus for HPV-Induced Cancers. Front Immunol 2020;11:586796. [PMID: 33488587 DOI: 10.3389/fimmu.2020.586796] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Li S, Zhang W, Jiang K, Shan H, Shi M, Chen B, Hua Z. Nanobody against the E7 oncoprotein of human papillomavirus 16. Mol Immunol 2019;109:12-9. [PMID: 30849663 DOI: 10.1016/j.molimm.2019.02.022] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
6 Phaeton R, Jiang Z, Revskaya E, Fisher DR, Goldberg GL, Dadachova E. Beta emitters rhenium-188 and lutetium-177 are equally effective in radioimmunotherapy of HPV-positive experimental cervical cancer. Cancer Med 2016;5:9-16. [PMID: 26625938 DOI: 10.1002/cam4.562] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
7 Jiang Z, Albanese J, Kesterson J, Warrick J, Karabakhtsian R, Dadachova E, Phaëton R. Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer. Transl Oncol 2019;12:1289-95. [PMID: 31325765 DOI: 10.1016/j.tranon.2019.06.003] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Xue X, Wang B, Du W, Zhang C, Song Y, Cai Y, Cen D, Wang L, Xiong Y, Jiang P, Zhu S, Zhao KN, Zhang L. Generation of affibody molecules specific for HPV16 E7 recognition. Oncotarget 2016;7:73995-4005. [PMID: 27659535 DOI: 10.18632/oncotarget.12174] [Cited by in Crossref: 16] [Cited by in F6Publishing: 17] [Article Influence: 4.0] [Reference Citation Analysis]